Piramal Pharma Ltd
NSE:PPLPHARMA
Wall Street
Price Targets
PPLPHARMA Price Targets Summary
Piramal Pharma Ltd
According to Wall Street analysts, the average 1-year price target for PPLPHARMA is 165.75 INR with a low forecast of 131.3 INR and a high forecast of 189 INR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is PPLPHARMA's stock price target?
Price Target
165.75
INR
According to Wall Street analysts, the average 1-year price target for PPLPHARMA is 165.75 INR with a low forecast of 131.3 INR and a high forecast of 189 INR.
What is Piramal Pharma Ltd's Revenue forecast?
Projected CAGR
12%
For the last 1 year the compound annual growth rate for Piramal Pharma Ltd's revenue is 129%. The projected CAGR for the next 4 years is 12%.
What is Piramal Pharma Ltd's Operating Income forecast?
Projected CAGR
-12%
For the last 1 year the compound annual growth rate for Piramal Pharma Ltd's operating income is 101%. The projected CAGR for the next 4 years is -12%.